WORK Medical Technology Group LTD Ordinary Shares

WORK Medical Technology Group LTD Ordinary Shares

WOK · NASDAQ · Healthcare / Medical Devices

1.20USD-0.05 (-4.00%)

Price History

Full chart

Market Stats

Previous Close1.25
Open1.24
Day Range1.20 – 1.30
52-Week Range1.75 – 105,000.00
Volume32.39K
Market Cap8.09M
P/E (TTM)0.00
Forward P/E0.00
EPS-260.72
Dividend Yield0.00%
Beta1.75
50-Day Avg2.04
200-Day Avg113.69

About

WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Shuang Wu
  • Employees238
  • HeadquartersNo. 2 Tonghuinan Road, Hangzhou, China, USA
  • Websitehttps://www.workmedtech.com

Leadership

  • Mr. Shuang WuChairman & CEO · b. 1983
  • Mr. Ningfang LiangChief Financial Officer · b. 1972
  • Mr. Baiming YuCOO & Director · b. 1971

Financials

Income Statement

Currency: USD2020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue52.53M45.86M19.71M13.57M11.51M9.85M
Growth (%)--12.68%-57.02%-31.18%-15.18%-14.41%
Cost of Revenue41.68M37.22M15.29M9.42M8.64M7.50M
Gross Profit10.85M8.64M4.42M4.14M2.87M2.34M
Gross Margin20.65%18.84%22.42%30.54%24.93%23.81%
Operating Expense4.86M965.34K2.59M3.66M6.57M4.84M
Operating Income5.99M7.67M1.82M486.46K-3.70M-2.50M
Operating Margin11.40%16.73%9.26%3.59%-32.14%-25.34%
EBITDA4.75M11.87M4.72M2.08M-1.71M339.37K
EBITDA Margin9.04%25.87%23.96%15.34%-14.90%3.45%
Net Income1.16M5.96M865.21K112.03K-3.49M-1.07M
Net Income Margin2.22%12.99%4.39%0.83%-30.35%-10.89%
R&D797.38K186.45K183.90K301.64K302.51K435.31K
R&D as % of Total Revenue1.52%0.41%0.93%2.22%2.63%4.42%
Interest Expense260.02K329.52K351.00K367.32K557.57K503.52K
Interest Expense % of Total Revenue0.50%0.72%1.78%2.71%4.85%5.11%

Balance Sheet

Currency: USD2020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets56.20M30.66M25.54M29.96M36.25M33.16M
Total Liabilities50.27M19.26M14.35M18.97M20.18M11.99M
Total Equity4.90M10.04M10.00M9.88M13.19M18.35M
Cash200.40K508.71K731.18K1.60M6.56M4.09M
Total Debt4.05M6.60M6.30M9.10M13.47M6.45M
Net Debt3.85M6.09M5.57M7.50M6.91M2.36M

Cash Flow

Currency: USD2020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow27.20M-7.18M-2.26M2.21M-2.23M6.24M
Investing Cash Flow-16.84M-60.00K-1.35M-583.30K-9.06M-7.61M
Financing Cash Flow-10.28M7.99M3.57M-728.72K15.66M-898.21K
Capital Expenditure17.55M60.00K2.01M583.30K9.26M1.33M
Free Cash Flow9.65M-7.24M-4.27M1.63M-11.49M4.91M
FCF to OCF35.48%100.84%189.09%73.60%515.53%78.66%

Earnings

Report DateFeb 14, 2025Aug 25, 2025
EPS Estimate0.000.00
EPS Actual-0.290.09
Surprise--
Timing--

Key Statistics & Ratios

Market Cap8.09M
Enterprise Value11.68M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.75
Price / Book0.28
EPS-260.72
Book Value1,855.16
Revenue (TTM)10.72M
Gross Profit (TTM)1.82M
EBITDA-3.37M
Profit Margin-41.95%
Operating Margin-65.35%
Return on Equity-19.23%
Return on Assets-6.73%
Shares Outstanding4.42M
Shares Float15.40K
Beta1.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.46%
Insiders
0.00%
Retail / Other
99.54%

Top Institutional Holders

  • North Star Investment Management Corp
    1020.00%
  • Caitong International Asset Management Co., Limited.
    30.00%
  • Bank of America Corp
    00.00%
  • UBS Group AG
    00.00%

Stock Splits

  • Jun 18, 20261:100
  • Dec 29, 20251:100
  • Oct 21, 20251:100